semaglutide care credit Weight Loss Financing: Bariatric Surgery, GLP-1, and More​ CareCredit Financing | Flexible Health

Protect From Direct Sunlight

Cell 185 , 38073822.e12 (2022)

According to NICE guideline NG28, GLP-1 receptor agonists should be considered when: Triple therapy (metformin and two other oral drugs) is not effective, not tolerated, or contraindicated The patient has a BMI 35 kg/m (or lower in people of Black, Asian and other minority ethnic groups) and specific obesity-related comorbidities The patient has a BMI 40% reduction in non-HDL cholesterol GLP-1 receptor agonist for glycaemic control and weight management (with secondary lipid benefits) Ezetimibe if non-HDL cholesterol reduction is insufficient Lifestyle interventions addressing diet, exercise, and weight Monitoring and follow-up are essential components of cholesterol management

They are not intended to diagnose or treat medical conditions